Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Open Access Highly Access

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen

Michael Mahler*, Reinout Raijmakers, Cornelia Dähnrich, Martin Blüthner and Marvin J Fritzler

Arthritis Research & Therapy 2005, 7:R704-R713 doi:10.1186/ar1729

Accesses  

  • Last 30 days: 31 accesses
  • Last year: 791 accesses
  • All time: 8969 accesses

Cited by

BioMed Central: 3 citations

Editorial   Free

The changing landscape of the clinical value of the PM/Scl autoantibody system

Michael Mahler, Marvin J Fritzler Arthritis Research & Therapy 2009, 11:106 (26 March 2009)

Abstract | Full text | PDF | PubMed

Research article   Open Access

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

Katharina Hanke, Claudia S Brückner, Cornelia Dähnrich, Dörte Huscher, Lars Komorowski, Wolfgang Meyer, Anthonia Janssen, Marina Backhaus, Mike Becker, Angela Kill, Karl Egerer, Gerd R Burmester, Falk Hiepe, Wolfgang Schlumberger, Gabriela Riemekasten Arthritis Research & Therapy 2009, 11:R22 (16 February 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article   Open Access

Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus

Michael Mahler, Aderajew Waka, F Hiepe, Marvin J Fritzler Arthritis Research & Therapy 2007, 9:R68 (18 July 2007)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations